Antithrombotic Drugs, Anti-Bleeding Drugs, Drugs Acting Tender

• Country: Estonia
• Summary: Antithrombotic Drugs, Anti-Bleeding Drugs, Drugs Acting on the Cardiovascular System, all other Therapeutic Agents, other Hematological Agents
• EET Ref No: 136094021
• Deadline: 23 Mar 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: EUR 76000.00
• Notice Type: Tender
• Document Ref. No.: 116815-2026
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• For the purchase of anti-thrombotic drugs, anti-bleeding drugs, drugs acting on the cardiovascular system, all other therapeutic agents, other hematological agents / Basis of elimination and qualification conditions: See procurement of the basic documents Sodium heparin Purchase of sodium heparin with the active ingredient of the medicine / Basis of disposal and qualification conditions: See the basic procurement documents Enoxaparin sodium Buying enoxaparin sodium with the active ingredient of the drug / Basics of elimination and qualification conditions: See basic procurement documents Tirofiban Purchase of tirofiban with the active ingredient of the drug / Basis of disposal and qualification conditions: See the basic procurement documents Alteplase Buying alteplase with the active ingredient of the drug / Basics of disposal and qualification conditions: See basic procurement documents Tenekteplas Purchase of tenecteplas with the active ingredient of the drug / Basis of disposal and qualification conditions: See the basic procurement documents Rivaroxaban Buying rivaroxaban with the active ingredient of the medicine / Grounds for elimination and qualification conditions: See the basic procurement documents Apixaban Purchase of apixaban with the active ingredient of the drug / Basis of disposal and qualification conditions: See the basic procurement documents Edoxaban The drug's active ingredient is edoxaban purchase / Grounds for disposal and qualification conditions: See the basic procurement documents Fondaparinux sodium Purchase of the active ingredient fondaparinux sodium / Basis of elimination and qualification conditions: See the basic procurement document...
• Documents:

 Tender Notice